Literature DB >> 2826500

Inhibition of growth and induction of enzyme activities in a clonal human hepatoma cell line (Li-7A): comparison of the effects of epidermal growth factor and an anti-epidermal growth factor receptor antibody.

A F Knowles1.   

Abstract

A cloned human hepatoma cell line (Li-7A), possessing epidermal growth factor (EGF) receptors numbering in the range of 10-20 pmol/10(6) cells, was inhibited in its growth by EGF as well as an antagonist monoclonal antibody (MoAb) to the EGF receptor. The mode of action of the two ligands of EGF receptors appeared to be different as indicated by the following results: 1) EGF induced marked alteration in cell morphology, whereas the antibody did not; 2) cellular protein accumulated in the EGF-treated cells but not in the antibody treated cells; and 3) ectoATPase activities were greatly enhanced in Li-7A cells treated with EGF and cholera toxin but were unaffected in cells treated with antibody and cholera toxin. The last result also suggests that expression of ectoATPase activities is under the regulation of both EGF and cholera toxin. Li-7A cells provide an additional valuable experimental system for the study of EGF action, as well as the interactive effects of EGF and cholera toxin. The enrichment of the ATPase activities in the EGF-cholera toxin-treated cells can be exploited for the detailed study and isolation of these enzymes and elucidation of their physiological functions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2826500     DOI: 10.1002/jcp.1041340113

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

Review 1.  Monoclonal antibodies to epidermal growth factor receptors in studies of receptor structure and function.

Authors:  T Kawamoto; G H Sato; K Takahashi; M Nishi; S Taniguchi; J D Sato
Journal:  Cytotechnology       Date:  1990-05       Impact factor: 2.058

2.  Neuroblast cell death in ovo and in culture: interaction of ethanol and neurotrophic factors.

Authors:  H Rahman; S Kentroti; A Vernadakis
Journal:  Neurochem Res       Date:  1994-12       Impact factor: 3.996

3.  Characterization of a monoclonal antibody directed against the epidermal growth factor receptor binding site.

Authors:  R Pellegrini; F Centis; S Martignone; A Mastroianni; E Tagliabue; E Tosi; S Ménard; M I Colnaghi
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

4.  A 34-kd protein with strong homology to ras-like proteins inhibits epidermal growth factor activity.

Authors:  D S Strayer; J Mathew
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

5.  Prevention of tumor metastasis formation by anti-variant CD44.

Authors:  S Seiter; R Arch; S Reber; D Komitowski; M Hofmann; H Ponta; P Herrlich; S Matzku; M Zöller
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

6.  Extracellular ATP and adenosine induce cell apoptosis of human hepatoma Li-7A cells via the A3 adenosine receptor.

Authors:  Long T Wen; Aileen F Knowles
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

7.  In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model.

Authors:  Fernanda B Morrone; Diogo L Oliveira; Patrícia Gamermann; Joseli Stella; Suzana Wofchuk; Márcia R Wink; Luise Meurer; Maria Isabel A Edelweiss; Guido Lenz; Ana Maria O Battastini
Journal:  BMC Cancer       Date:  2006-09-23       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.